NorthCoast Asset Management LLC reduced its stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 9.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 103,187 shares of the medical device company’s stock after selling 11,299 shares during the quarter. Cooper Companies, Inc. (The) accounts for 2.9% of NorthCoast Asset Management LLC’s holdings, making the stock its 5th biggest holding. NorthCoast Asset Management LLC owned approximately 0.21% of Cooper Companies, Inc. (The) worth $24,705,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Toronto Dominion Bank grew its holdings in shares of Cooper Companies, Inc. (The) by 57.1% during the 1st quarter. Toronto Dominion Bank now owns 13,208 shares of the medical device company’s stock worth $2,640,000 after purchasing an additional 4,802 shares in the last quarter. Scout Investments Inc. grew its holdings in shares of Cooper Companies, Inc. (The) by 29.3% during the 2nd quarter. Scout Investments Inc. now owns 116,320 shares of the medical device company’s stock worth $27,849,000 after purchasing an additional 26,370 shares in the last quarter. Dai Ichi Life Insurance Company Ltd acquired a new stake in shares of Cooper Companies, Inc. (The) during the 1st quarter worth $206,000. Arizona State Retirement System grew its holdings in shares of Cooper Companies, Inc. (The) by 0.5% during the 1st quarter. Arizona State Retirement System now owns 20,200 shares of the medical device company’s stock worth $4,038,000 after purchasing an additional 100 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its holdings in shares of Cooper Companies, Inc. (The) by 5.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 244,686 shares of the medical device company’s stock worth $58,583,000 after purchasing an additional 13,004 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.

Several analysts have recently issued reports on COO shares. Zacks Investment Research lowered Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a report on Monday, May 22nd. Stifel Nicolaus increased their target price on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, June 2nd. Jefferies Group LLC reissued a “buy” rating and set a $250.00 target price (up from $220.00) on shares of Cooper Companies, Inc. (The) in a report on Saturday, June 3rd. Oppenheimer Holdings, Inc. set a $225.00 target price on Cooper Companies, Inc. (The) and gave the stock a “hold” rating in a report on Saturday, June 3rd. Finally, BMO Capital Markets reissued an “outperform” rating and set a $255.00 target price (up from $220.00) on shares of Cooper Companies, Inc. (The) in a report on Monday, June 5th. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Cooper Companies, Inc. (The) presently has a consensus rating of “Buy” and an average target price of $246.89.

Shares of Cooper Companies, Inc. (COO) traded up 2.72% during mid-day trading on Friday, hitting $251.48. The company had a trading volume of 577,385 shares. The company has a market capitalization of $12.29 billion, a PE ratio of 37.70 and a beta of 0.59. The company’s 50-day moving average is $245.26 and its 200 day moving average is $222.76. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The business had revenue of $556 million during the quarter, compared to analysts’ expectations of $552.32 million. During the same period in the previous year, the business earned $2.30 earnings per share. The firm’s revenue was up 8.0% on a year-over-year basis. On average, equities research analysts forecast that Cooper Companies, Inc. will post $9.72 EPS for the current fiscal year.

In related news, VP Randal Golden sold 1,621 shares of the business’s stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $243.65, for a total transaction of $394,956.65. Following the completion of the transaction, the vice president now directly owns 1,731 shares in the company, valued at $421,758.15. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Paul L. Remmell sold 9,294 shares of the business’s stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total value of $2,309,187.24. Following the transaction, the chief executive officer now owns 6,186 shares of the company’s stock, valued at $1,536,973.56. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,015 shares of company stock valued at $4,193,502. 1.60% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This report was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/09/09/northcoast-asset-management-llc-trims-stake-in-cooper-companies-inc-the-coo.html.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.